The myelin-derived antigen provides the disease-relevant immune stimulus, while the adjuvant strengthens activation of autoreactive T cells. Together, these components create conditions in which an immune response directed toward myelin can develop in a susceptible animal. This design allows investigators to examine how antigen-specific activation becomes linked to central nervous system inflammation and demyelination.
Pertussis toxin is often included to promote autoreactive T-cell activity and facilitate their entry into the brain and spinal cord. By supporting this transition from peripheral immune activation to central nervous system involvement, it helps produce neurological disease features that can be compared across experimental conditions.
The model connects several measurable stages: immune-cell infiltration, inflammatory signaling, myelin damage, and neurological deficits. Considering these stages together helps distinguish an early inflammatory response from later tissue injury or clinical expression. Histological findings can complement clinical monitoring, providing a more complete picture of how immune activity relates to central nervous system damage.
A typical induction workflow begins by selecting a susceptible animal and administering a myelin-derived antigen with an adjuvant. Pertussis toxin may also be used to promote autoreactive T-cell entry into the brain and spinal cord. Investigators then monitor the animals clinically and evaluate tissues histologically to characterize inflammation, demyelination, and neurological disease.
Researchers can assess neurological deficits through clinical monitoring and examine immune-cell infiltration, inflammatory signaling, and myelin damage through histological analysis. These complementary outcomes reveal both functional disease expression and tissue-level pathology. Comparing the two types of evidence helps determine whether an intervention affects visible neurological impairment, central nervous system inflammation, demyelination, or several features at once.
The model supports investigation of autoimmune inflammation, host immune responses, and neuroimmunological mechanisms relevant to multiple sclerosis. It also provides a framework for studying interventions and therapeutic targets associated with inflammatory damage in the central nervous system. Within immunology and infection research, the system is additionally relevant to questions involving autoimmune and infectious neuroinflammation.